November 27, 2020 News Recap It has been an eventful few months as it pertains to how Sorrento Therapeutics will strategically move from ...

The Biotech landscape has been slowly shifting awareness to the likes of Antibodies & Therapeutics, especially after the President was t...

Recap Sorrento Therapeutics has run over 100% since it hit bottom at $5.77. Hindenburg put out hit piece on SRNE scaring off many retail...

Good news? Sorrento Therapeutics annouces 2 major catalysts in the past week. The first came on August 19,2020. The company announced it ...

Sorrento shareholders have been on a wild ride as of late. I will briefly give you my view of the current events, what my thoughts are o...

Opgen follow up Tweet with PR stating, "As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press relea...

Novavax in a recent Phase I study showed that it's vaccine elicited an immune response and was moderately safe. Therefore, the phase I st...

As promised, I have worked with the team on dialing in a tradeable/actionable boom calendar. I suggest you reread the last four articles...

Before I begin, I might as well share with you a snippet about me. I started out my career at 24 as a financial advisor for five years, ...

Dr. Robert Hariri has been making headlines recently and for good reason. Dr. Hariri is the CEO of Celularity Inc. and a straight shooter...